Anchiano Therapeutics Ltd., of Cambridge, Mass., appointed Steve DiPalma chief financial officer.
Biosig Technologies Inc., of Westport, Conn., appointed Dennis Purcell to the board of its majority-owned subsidiary Viralclear Pharmaceuticals Inc.
Centogene AG, of Rostock, Germany, appointed Angelos Baxevanis senior vice president communication and marketing.
Immunocore Ltd., of Oxfordshire, U.K., appointed Brian Di Donato chief financial officer and head of strategy.
Janssen Research & Development LLC, a unit of Johnson & Johnson, of New Brunswick, N.J., appointed Najat Khan chief data science officer.
Lodo Therapeutics Corp., of New York, appointed Donald R. Marvin executive vice president and chief financial officer.
Mimedx Group Inc., of Marietta, Ga., appointed William L. Phelan senior vice president and chief accounting officer.
Respirerx Pharmaceuticals Inc., of Glen Rock, N.J., appointed Timothy Jones president and CEO.
Schrodinger Inc., of New York, appointed Jeffrey A. Chodakewitz and Gary Ginsberg to its board.